Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Oct;80(2):269–277. doi: 10.1111/j.1476-5381.1983.tb10030.x

Induction of zymosan-air-pouch inflammation in rats and its characterization with reference to the effects of anticomplementary and anti-inflammatory agents.

S Konno, S Tsurufuji
PMCID: PMC2045017  PMID: 6652379

Abstract

Induction of an experimental inflammation of the air-pouch type with the aid of zymosan (known to activate the alternative pathway of the complement system) was carried out in an attempt to induce a reproducible inflammatory model suitable for quantitative studies. Rats were injected subcutaneously with 8 ml of air on the dorsal surface to make an air-pouch, followed 24h later by 4 ml of 1.6% (w/v) zymosan suspension. This induced inflammatory responses. Treatment with zymosan suspension provoked exudation of fluid, accumulation of polymorphnuclear leukocytes (PMN) in the pouch and the development of granulation tissue as a wall of the pouch. Approximately half of the PMN in the pouch formed a characteristic layer of aggregated cells sticking onto the inner surface of the pouch wall. They were counted after being completely disaggregated by means of incubation with trypsin. In preliminary experiments with potential anti-inflammatory drugs, local application of a novel anti-complementary agent, K-76COONa, inhibited leukocyte accumulation in the pouch, whereas the potent anti-inflammatory agent, dexamethasone, was ineffective. By contrast, exudation of the pouch fluid was effectively inhibited by dexamethasone but not by K-76COONa.

Full text

PDF
269

Images in this article

273Figure 3
on p.273
273Figure 4
on p.273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrios R., Santos G. G., Figueroa J., Reyes P. A. Zymosan-induced experimental hypersensitivity pneumonitis in rabbits. Am J Pathol. 1980 Jun;99(3):731–740. [PMC free article] [PubMed] [Google Scholar]
  2. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  3. Blackwell G. J., Flower R. J., Nijkamp F. P., Vane J. R. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol. 1978 Jan;62(1):79–89. doi: 10.1111/j.1476-5381.1978.tb07009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borel J. F., Feurer C. In-vivo effects of anti-inflammatory and other drugs on granulocyte emigration in the rabbit skin collection chamber. J Pathol. 1978 Feb;124(2):85–93. doi: 10.1002/path.1711240204. [DOI] [PubMed] [Google Scholar]
  5. Bray M. A., Gordon D. Prostaglandin production by macrophages and the effect of anti-inflammatory drugs. Br J Pharmacol. 1978 Aug;63(4):635–642. doi: 10.1111/j.1476-5381.1978.tb17276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Claesson H. E., Lundberg U., Malmsten C. Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP. Biochem Biophys Res Commun. 1981 Apr 30;99(4):1230–1237. doi: 10.1016/0006-291x(81)90751-8. [DOI] [PubMed] [Google Scholar]
  7. Edwards J. H., Wagner J. C., Seal R. M. Pulmonary responses to particulate materials capable of activating the alternative pathway of complement. Clin Allergy. 1976 Mar;6(2):155–164. doi: 10.1111/j.1365-2222.1976.tb01893.x. [DOI] [PubMed] [Google Scholar]
  8. Fukuhara M., Tsurufuji S. The effect of locally injected anti-inflammatory drugs on the carrageenin granuloma in rats. Biochem Pharmacol. 1969 Feb;18(2):475–484. doi: 10.1016/0006-2952(69)90223-8. [DOI] [PubMed] [Google Scholar]
  9. Green A. P., Mangan F. R. The effect of steroidal and non-steroidal antiinflammatory drugs on chronic muscle inflammation. J Pharm Pharmacol. 1980 May;32(5):319–322. doi: 10.1111/j.2042-7158.1980.tb12928.x. [DOI] [PubMed] [Google Scholar]
  10. Higgs G. A., Flower R. J., Vane J. R. A new approach to anti-inflammatory drugs. Biochem Pharmacol. 1979 Jun 15;28(12):1959–1961. doi: 10.1016/0006-2952(79)90651-8. [DOI] [PubMed] [Google Scholar]
  11. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A. 1980 May;77(5):2533–2536. doi: 10.1073/pnas.77.5.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hong K., Kinoshita T., Miyazaki W., Izawa T., Inoue K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J Immunol. 1979 Jun;122(6):2418–2423. [PubMed] [Google Scholar]
  13. Hong S. L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976 May;73(5):1730–1734. doi: 10.1073/pnas.73.5.1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ishikawa H., Mori Y., Tsurufuji S. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation. Eur J Pharmacol. 1969 Aug;7(2):201–205. doi: 10.1016/0014-2999(69)90011-9. [DOI] [PubMed] [Google Scholar]
  15. Ishikawa H., Mori Y., Tsurufuji S. [The inhibitory effect of some steroidal anti-inflammatory agents on leukocyte emigration by the carboxymethyl cellulose pouch method]. Yakugaku Zasshi. 1968 Nov;88(11):1491–1493. doi: 10.1248/yakushi1947.88.11_1491. [DOI] [PubMed] [Google Scholar]
  16. Keystone E. C., Schorlemmer H. U., Pope C., Allison A. C. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 1977 Sep-Oct;20(7):1396–1401. doi: 10.1002/art.1780200714. [DOI] [PubMed] [Google Scholar]
  17. Ohuchi K., Yoshino S., Kanaoka K., Tsurufuji S., Levine L. A possible role of arachidonate metabolism in allergic air pouch inflammation in rats. Anti-inflammatory effect of indomethacin and dexamethasone and the level of prostaglandin E2 in the exudate. Int Arch Allergy Appl Immunol. 1982;68(4):326–331. doi: 10.1159/000233121. [DOI] [PubMed] [Google Scholar]
  18. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  19. Robinson D. R., McGuire M. B., Bastian D., Kantrowitz F., Levine L. The effects of anti-inflammatory drugs on prostaglandin production by rheumatoid synovial tissue. Prostaglandins Med. 1978 Dec;1(6):461–477. doi: 10.1016/0161-4630(78)90117-9. [DOI] [PubMed] [Google Scholar]
  20. Rouzer C. A., Scott W. A., Cohn Z. A., Blackburn P., Manning J. M. Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4928–4932. doi: 10.1073/pnas.77.8.4928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schorlemmer H. U., Edwards J. H., Davies P., Allison A. C. Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathway. Clin Exp Immunol. 1977 Feb;27(2):198–207. [PMC free article] [PubMed] [Google Scholar]
  22. Tsurufuji S., Yoshino S., Ohuchi K. Induction of an allergic air-pouch inflammation in rats. Int Arch Allergy Appl Immunol. 1982;69(3):189–198. doi: 10.1159/000233170. [DOI] [PubMed] [Google Scholar]
  23. Ward P. A. The chemosuppression of chemotaxis. J Exp Med. 1966 Aug 1;124(2):209–226. doi: 10.1084/jem.124.2.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Webster R. O., Hong S. R., Johnston R. B., Jr, Henson P. M. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology. 1980 Jun;2(3):201–219. doi: 10.1016/0162-3109(80)90050-8. [DOI] [PubMed] [Google Scholar]
  25. Weissmann G., Dukor P., Zurier R. B. Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol. 1971 Jun 2;231(22):131–135. doi: 10.1038/newbio231131a0. [DOI] [PubMed] [Google Scholar]
  26. Wilkinson P. C. Characterization of the chemotactic activity of casein for neutrophil leucocytes and macrophages. Experientia. 1972 Sep 15;28(9):1051–1052. doi: 10.1007/BF01918666. [DOI] [PubMed] [Google Scholar]
  27. Williams T. J., Jose P. J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med. 1981 Jan 1;153(1):136–153. doi: 10.1084/jem.153.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Williams T. J. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol. 1979 Mar;65(3):517–524. doi: 10.1111/j.1476-5381.1979.tb07860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES